Ptc Therapeutics (PTCT) Receivables (2013 - 2026)
Ptc Therapeutics (PTCT) recorded Receivables of $239.04 million in Q2 2026, up 21.9% from $196.13 million a year earlier and up 8.7% from the prior quarter.
Ptc Therapeutics (PTCT) Receivables (2013 - 2026) Analysis & Trends
At the end of FY2025, Ptc Therapeutics reported Receivables of $181.62 million, up 14.5% from FY2024.
- Annual Receivables has a five-year compound annual growth rate of 21.0% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $158.55 million in FY2024 (-1.5%), $161.02 million in FY2023 (+3.5%), $155.61 million in FY2022 (+40.9%) and $110.46 million in FY2021 (+58.0%).
- The Q2 2026 figure is the highest quarterly Receivables in data going back to Q4 2013.
- On a year-over-year basis, Receivables has increased for six consecutive quarters, with growth averaging 8.9% over the last eight quarters.
- Peak year-over-year performance for Receivables in the last five years was growth of 72.5% in Q2 2022, against a decline of 1.7% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $219.92 million (Q1 2026), $181.62 million (Q4 2025) and $203.07 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Ptc Therapeutics | 5.19 Bn | -2.56 Bn | 340.60 Mn | 239.04 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 239.04 Mn |
| Mar 31, 2026 | 219.92 Mn |
| Dec 31, 2025 | 181.62 Mn |
| Sep 30, 2025 | 203.07 Mn |
| Jun 30, 2025 | 196.13 Mn |
| Mar 31, 2025 | 210.50 Mn |
| Dec 31, 2024 | 158.55 Mn |
| Sep 30, 2024 | 199.98 Mn |
| Jun 30, 2024 | 187.15 Mn |
| Mar 31, 2024 | 198.46 Mn |
| Dec 31, 2023 | 161.02 Mn |
| Sep 30, 2023 | 167.12 Mn |
| Jun 30, 2023 | 177.90 Mn |
| Mar 31, 2023 | 201.87 Mn |
| Dec 31, 2022 | 155.61 Mn |
| Sep 30, 2022 | 124.46 Mn |
| Jun 30, 2022 | 135.94 Mn |
| Mar 31, 2022 | 141.29 Mn |
| Dec 31, 2021 | 110.46 Mn |
| Sep 30, 2021 | 96.65 Mn |
Ptc Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=PTCT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "PTCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=PTCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();